Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a mass in the pancreas and a suspected diagnosis of pancreatic ductal adenocarcinoma (a type of pancreatic cancer) that requires either an endoscopic ultrasound with a needle biopsy or surgery
- People who are 18 years of age or older
- People who have not yet received any treatment for pancreatic cancer
Who may not be able to join:
- People who do not wish to take part in or refuse to follow the study protocol
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: REGIS SOUCHE, University Hospital, Montpellier
Phone: 467337072
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of each protein contained in Cytolyt® for the positive diagnosis of pancreatic ductal adenocarcinoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.